Latest Reports

  • Allergic Asthma - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Allergic Asthma - Pipeline Review, H1 2014 Summary Global Markets Directs, Allergic Asthma - Pipeline Review, H1 2014, provides an overview of the Allergic Asthmas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Allergic Asthma, complete wit

  • Anthrax - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Anthrax - Pipeline Review, H1 2014 Summary Global Markets Directs, Anthrax - Pipeline Review, H1 2014, provides an overview of the Anthraxs therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Anthrax, complete with comparative analysis at variou

  • Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2014 Summary Global Markets Directs, Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2014, provides an overview of the Wet (Neovascular / Exudative) Macular Degenerations therapeutic pipeline. This r

  • Esophageal Cancer - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Esophageal Cancer - Pipeline Review, H1 2014 Summary Global Markets Directs, Esophageal Cancer - Pipeline Review, H1 2014, provides an overview of the Esophageal Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Esophageal Cancer, comp

  • Dementia - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Dementia - Pipeline Review, H1 2014 Summary Global Markets Directs, Dementia - Pipeline Review, H1 2014, provides an overview of the Dementias therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Dementia, complete with comparative analysis at va

  • Post-Operative Pain - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Post-Operative Pain - Pipeline Review, H1 2014 Summary Global Markets Directs, Post-Operative Pain - Pipeline Review, H1 2014, provides an overview of the Post-Operative Pains therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Post-Operative Pa

  • Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2014 Summary Global Markets Directs, Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2014, provides an overview of the Recurrent Glioblastoma Multiforme (GBM)s therapeutic pipeline. This report provides comprehensive info

  • Chemotherapy Induced Neutropenia - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Chemotherapy Induced Neutropenia - Pipeline Review, H1 2014 Summary Global Markets Directs, Chemotherapy Induced Neutropenia - Pipeline Review, H1 2014, provides an overview of the Chemotherapy Induced Neutropenias therapeutic pipeline. This report provides comprehensive information on the therap

  • Critical Limb Ischemia - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Critical Limb Ischemia - Pipeline Review, H1 2014 Summary Global Markets Directs, Critical Limb Ischemia - Pipeline Review, H1 2014, provides an overview of the Critical Limb Ischemias therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Critical

  • Diabetic Neuropathic Pain - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Diabetic Neuropathic Pain - Pipeline Review, H1 2014 Summary Global Markets Directs, Diabetic Neuropathic Pain - Pipeline Review, H1 2014, provides an overview of the Diabetic Neuropathic Pains therapeutic pipeline. This report provides comprehensive information on the therapeutic development for

  • Cancer Cachexia - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Cancer Cachexia - Pipeline Review, H1 2014 Summary Global Markets Directs, Cancer Cachexia - Pipeline Review, H1 2014, provides an overview of the Cancer Cachexias therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cancer Cachexia, complete wit

  • Thyroid Cancer - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Thyroid Cancer - Pipeline Review, H1 2014 Summary Global Markets Directs, Thyroid Cancer - Pipeline Review, H1 2014, provides an overview of the Thyroid Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Thyroid Cancer, complete with co

  • Allergic Rhino-Conjunctivitis - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Allergic Rhino-Conjunctivitis - Pipeline Review, H1 2014 Summary Global Markets Directs, Allergic Rhino-Conjunctivitis - Pipeline Review, H1 2014, provides an overview of the Allergic Rhino-Conjunctivitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic dev

  • Insulin Resistance - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Insulin Resistance - Pipeline Review, H1 2014 Summary Global Markets Directs, Insulin Resistance - Pipeline Review, H1 2014, provides an overview of the Insulin Resistances therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Insulin Resistance,

  • Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2014 Summary Global Markets Directs, Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2014, provides an overview of the Cognitive Impairment Associated With Schizophrenia (CIAS)s therapeu

  • Retinal Degeneration - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Retinal Degeneration - Pipeline Review, H1 2014 Summary Global Markets Directs, Retinal Degeneration - Pipeline Review, H1 2014, provides an overview of the Retinal Degenerations therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Retinal Degene

  • Androgenic Alopecia - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Androgenic Alopecia - Pipeline Review, H1 2014 Summary Global Markets Directs, Androgenic Alopecia - Pipeline Review, H1 2014, provides an overview of the Androgenic Alopecias therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Androgenic Alopec

  • Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H1 2014 Summary Global Markets Directs, Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H1 2014, provides an overview of the Methicillin-Susceptible Staphylococcus Aureus (MSSA) In

  • Hemorrhage - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Hemorrhage - Pipeline Review, H1 2014 Summary Global Markets Directs, Hemorrhage - Pipeline Review, H1 2014, provides an overview of the Hemorrhages therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hemorrhage, complete with comparative analys

  • Bacterial Conjunctivitis - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Bacterial Conjunctivitis - Pipeline Review, H1 2014 Summary Global Markets Directs, Bacterial Conjunctivitis - Pipeline Review, H1 2014, provides an overview of the Bacterial Conjunctivitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Ba

  • Left Ventricular Dysfunction - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Left Ventricular Dysfunction - Pipeline Review, H1 2014 Summary Global Markets Directs, Left Ventricular Dysfunction - Pipeline Review, H1 2014, provides an overview of the Left Ventricular Dysfunctions therapeutic pipeline. This report provides comprehensive information on the therapeutic develo

  • Peripheral Neuropathic Pain - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Peripheral Neuropathic Pain - Pipeline Review, H1 2014 Summary Global Markets Directs, Peripheral Neuropathic Pain - Pipeline Review, H1 2014, provides an overview of the Peripheral Neuropathic Pains therapeutic pipeline. This report provides comprehensive information on the therapeutic developme

  • Corticosteroid-Responsive Dermatoses - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Corticosteroid-Responsive Dermatoses - Pipeline Review, H1 2014 Summary Global Markets Directs, Corticosteroid-Responsive Dermatoses - Pipeline Review, H1 2014, provides an overview of the Corticosteroid-Responsive Dermatosess therapeutic pipeline. This report provides comprehensive information o

  • Burkholderia Infections - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Burkholderia Infections - Pipeline Review, H1 2014 Summary Global Markets Directs, Burkholderia Infections - Pipeline Review, H1 2014, provides an overview of the Burkholderia Infectionss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Burkh

  • Liposarcoma - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Liposarcoma - Pipeline Review, H1 2014 Summary Global Markets Directs, Liposarcoma - Pipeline Review, H1 2014, provides an overview of the Liposarcomas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Liposarcoma, complete with comparative an

  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2014 Summary Global Markets Directs, Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2014, provides an overview of the Recurrent Head And Neck Cancer Squamous Cell Carcinomas therapeutic pipel

  • Sedation - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Sedation - Pipeline Review, H1 2014 Summary Global Markets Directs, Sedation - Pipeline Review, H1 2014, provides an overview of the Sedations therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Sedation, complete with comparative analysis at va

  • Contraception - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Contraception - Pipeline Review, H1 2014 Summary Global Markets Directs, Contraception - Pipeline Review, H1 2014, provides an overview of the Contraceptions therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Contraception, complete with compar

  • Opioid Induced Side Effects - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Opioid Induced Side Effects - Pipeline Review, H1 2014 Summary Global Markets Directs, Opioid Induced Side Effects - Pipeline Review, H1 2014, provides an overview of the Opioid Induced Side Effectss therapeutic pipeline. This report provides comprehensive information on the therapeutic developme

  • Bone Degeneration - Pipeline Review, H1 2014


    $$2,000
    2014-06-30 00:00:00 | Published by: Global Markets Direct

    Bone Degeneration - Pipeline Review, H1 2014 Summary Global Markets Directs, Bone Degeneration - Pipeline Review, H1 2014, provides an overview of the Bone Degenerations therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Bone Degeneration, comp